Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133809 · ClinicalTrials.gov registry record · Phase 2
Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00133809: Completed Phase 2 study, sponsored by Emory University.
NCT00133809 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 8 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00133809, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This trial will study the ability of islet transplantation to restore glycemic control and achieve insulin independence in type 1 diabetic subjects with life-threatening hypoglycemia and unawareness, or recurrent hyperglycemia with ketoacidosis.
Primary Outcome
Independence from insulin injections is measured by the actual use of insulin by the study participants.
Interventions
- DRUG Transplantation of Human Islets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2002-07 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
What the finished NCT00133809 record still lists
NCT00133809 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Transplantation of Human Islets is the first listed.
NCT00133809 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00133809 about?
NCT00133809 is a clinical study titled "Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression". This trial will study the ability of islet transplantation to restore glycemic control and achieve insulin independence in type 1 diabetic subjects with life-threatening hypoglycemia and unawareness, or recurrent hyperglycemia with ketoacidosis.
What is the current status of trial NCT00133809?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2002-07. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00133809?
The interventions under investigation include: Transplantation of Human Islets (DRUG).
Who is sponsoring clinical trial NCT00133809?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00133809's enrollment target sits among peer trials
8 1990th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia